Drug intelligence / Profile preview

bilberry extract

Development stage
Phase 2
Lead developer
Indena
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Bilberry extract is derived from the fruit or leaves of the plant Vaccinium myrtillus. It is commonly used as a dietary supplement and herbal remedy. The primary active compounds in bilberry are anthocyanins and tannins, which have antioxidant properties. Bilberry extracts have been traditionally used for conditions related to vision (such as night vision), cardiovascular health (including circulation problems and high blood pressure), elevated blood sugar levels in diabetes, inflammatory bowel conditions, and as supportive treatment for short-term nonspecific diarrhea[1][2][3][5]. Mechanistically, laboratory studies suggest that bilberry polyphenols may inhibit amyloid fibril formation (relevant to neurodegenerative diseases), modulate oxidative stress defense enzymes such as heme oxygenase-1 and glutathione S-transferase-pi in retinal cells, inhibit angiogenesis via ERK 1/2 and Akt pathways, reduce inflammation by suppressing IL-6/STAT3 signaling in retinal tissue, induce apoptosis in cancer cell lines through modulation of Notch/WNT/NF-ĸB pathways[8]. However, robust clinical evidence supporting these uses is limited.

Brand names
airelleblack whortlesburren myrtledyeberryhuckleberryhurtleberrymyrtilli fructustrackleberrywhortleberrywineberry
Other names
Vaccinium myrtillusFructus myrtillibog bilberryHeidelbeerehuckleberrywhortleberry
02

Targets

HMOX1 (Heme oxygenase 1)AKT (RAC-alpha serine/threonine-protein kinase)MAPK3 (Mitogen-activated protein kinase 1)NOTCH (Neurogenic locus notch homolog protein 3)GSTP1 (Glutathione S-transferase P)

Beyond the preview

Go deeper on bilberry extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bilberry extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call